Pharmaceutical Industry Expects Revenue Boost Despite US Market Challenges
Indian drug companies are poised for improved revenue growth in the June quarter, driven by…
Pharmaceuticals
Neuraxpharm Expands Global Reach with Australian Launch
Neuraxpharm launches Australian subsidiary, marking significant milestone in international expansion
Pharmaceutical Company Refuses FDA Request to Withdraw Treatment Amid Patient Death Concerns
A drugmaker has declined an FDA request to pull a treatment from the market after…
Pakistan Prime Minister Criticizes DRAP for Excessive Bureaucracy
PM criticizes DRAP for red tape, vows to simplify regulations
AstraZeneca Invests $50 Billion in US Drug Production and R&D
AstraZeneca announces a massive investment of $50 billion in the US for drug production and…
British Columbia Cracks Down on Diabetes Drug Market Abuse
BC limits sales of two diabetes drugs to combat market abuse
Revolutionary Weight Loss Drugs: Unveiling the Multifaceted Benefits
Recent studies have shed light on the numerous benefits of weight loss drugs, extending beyond…
Cardiology Lawsuits on the Rise: 2025 Trends and Insights
The cardiology industry is facing a surge in lawsuits, with four notable cases in 2025.…
US-Australia Trade Tensions Escalate: Trump Flags Tariffs on Pharmaceuticals
The US has flagged 200 tariffs on Australian pharmaceuticals, sparking concerns over the impact on…